English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies

MPS-Authors
/persons/resource/persons50427

Meierhofer,  David
Mass Spectrometry (Head: David Meierhofer), Scientific Service (Head: Christoph Krukenkamp), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Xiao2019.pdf
(Publisher version), 819KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Xiao, Y., & Meierhofer, D. (2019). Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies. International Journal of Molecular Sciences, 20(15): E3672. doi:10.3390/ijms20153672.


Cite as: https://hdl.handle.net/21.11116/0000-0004-5B9C-7
Abstract
A significantly increased level of the reactive oxygen species (ROS) scavenger glutathione (GSH) has been identified as a hallmark of renal cell carcinoma (RCC). The proposed mechanism for increased GSH levels is to counteract damaging ROS to sustain the viability and growth of the malignancy. Here, we review the current knowledge about the three main RCC subtypes, namely clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chRCC), at the genetic, transcript, protein, and metabolite level and highlight their mutual influence on GSH metabolism. A further discussion addresses the question of how the manipulation of GSH levels can be exploited as a potential treatment strategy for RCC.